Saba, Nabil F.

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Ferris, R. L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., Harrington, K., Kasper, S., Vokes, E. E., Even, C., et al. (2016) · New England Journal of Medicine

Head and Neck Cancer StudiesCancer Immunotherapy and Biomarkers

Cited by 5,101

Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations

Ho, A. L., Brana, I., Haddad, R., Bauman, J., Bible, K., Oosting, S., Wong, D. J., Ahn, M.-J., Boni, V., Even, C., et al. (2021) · Journal of Clinical Oncology

Head and Neck Cancer StudiesLung Cancer Treatments and Mutations

Cited by 208

MAST1 drives cisplatin resistance in human cancers by rewiring cRaf-independent MEK activation

Jin, L., Chun, J., Pan, C., Li, D., Lin, R., Alesi, G. N., Wang, X., Kang, H.-B., Song, L., Wang, D., et al. (2018) · Cancer Cell

Melanoma and MAPK PathwaysMetal complexes synthesis and properties

Cited by 132

The Limitations of Artificial Intelligence in Head and Neck Oncology

Rao, K. N., Fernandez-Alvarez, V., Guntinas-Lichius, O., Sreeram, M. P., de Bree, R., Kowalski, L. P., Forastiere, A., Pace-Asciak, P., Rodrigo, J. P., Saba, N. F., et al. (2025) · Advances in Therapy

Artificial Intelligence in Healthcare and EducationAI in cancer detection

Cited by 33